Marinomed Biotech AG

Profile narrative

Marinomed Biotech AG operates under the aliases Marinomed Biotech and Marinomed Biotech AG. The company's headquarters is located in Korneuburg, Lower Austria, Austria. It is identified as a pharmaceutical firm engaged in the development and commercialisation of medical products. Its activities are focused on the European market, as indicated by references to the European Economic Area in incident reports. The firm maintains a corporate presence that is reflected in its official website and press releases.

On 1 April 2025, Marinomed Biotech AG disclosed that it fell victim to a cybercrime incident. The incident resulted in an unauthorized transfer of approximately 677,000 euros to parties outside the European Economic Area. In response, the company filed criminal charges with the relevant authorities. It also engaged external advisors to conduct a forensic investigation of the breach. Management stated that attempts to reverse the transaction or block the funds at the recipient bank have so far been unsuccessful, while liquidity remains unaffected.

On 1 November 2025, the company reported a similar cybercrime event. This later incident also involved an unauthorized transfer of roughly EUR 677,000 to entities outside the European Economic Area. Marinomed Biotech AG again filed criminal charges and enlisted external advisors to investigate. Efforts to reverse or block the transaction have not succeeded, although the management board affirmed that the company's liquidity remains secured. Both incidents are documented in news coverage from Kurier.at and an official advisory posted on the Marinomed website.

Incidents

2 incidents linked to this organisation.